oa South African Family Practice - Medifile : Atomoxetine and Ezetimibe
|Article Title||Medifile : Atomoxetine and Ezetimibe|
|© Publisher:||Medpharm Publications|
|Journal||South African Family Practice|
|Author||Marzelle Fivaz and J. Noble|
|Publication Date||Jan 2006|
|Pages||60 - 63|
Extracted from text ... Jan/Feb 2006; 20(1) SA Fam Pract 2006;48(1) 60 u ABSTRACT The first edition of Medifile for 2006 provides information on two new drug classes, Atomoxetine and Ezetimibe. Strattera(r) (Atomoxetine) is the first non-stimulant drug registered for the management of Attention Deficit Hyperactivity Disorder (ADHD). Ezetrol(r) (Ezetimibe) is an anti-hyperlipidaemic and selective cholesterol absorption inhibitor. The selective cholesterol absorption inhibitors are the first new class of cholesterol lowering drugs in 15 years. Both products were launched in South Africa in 2005. u NEW TREATMENT AVAILABLE FOR ADHD: ATOMOXETINE INTRODUCTION Attention deficit hyperactivity disorder (ADHD) occurs in 3- 10% of children.1 ..
Article metrics loading...